Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lou Gehrig Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01622088
What this trial is testing

Phase 3 Extension Study of Dexpramipexole in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 616
Not applicableStudy completedNCT03868345
What this trial is testing

Speech Analysis in ALS Patients

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig Disease
Barrow Neurological Institute 26
Not applicableLooking for participantsNCT01772602
What this trial is testing

The National Amyotrophic Lateral Sclerosis Registry

Who this might be right for
Amyotrophic Lateral Sclerosis
Centers for Disease Control and Prevention 30,000
Not applicableStudy completedNCT00821132
What this trial is testing

Genetics of Familial and Sporadic ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Familial Amyotrophic Lateral SclerosisALS With Frontotemporal Dementia (ALS/FTD)+4 more
Northwestern University 13,521
Large-scale testing (Phase 3)Active Not RecruitingNCT04297683
What this trial is testing

HEALEY ALS Platform Trial - Master Protocol

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 1,500
Early research (Phase 1)Looking for participantsNCT07401121
What this trial is testing

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Celosia Therapeutics Pty Ltd 15
Large-scale testing (Phase 3)Study completedNCT04615923
What this trial is testing

HEALEY ALS Platform Trial - Regimen D Pridopidine

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 163
Testing effectiveness (Phase 2)Study completedNCT00790582
What this trial is testing

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Forbes Norris MDA/ALS Research Center 109
Not applicableStudy completedNCT02464852
What this trial is testing

Assessment of the Effects of Sheffield Support Snood in MND Patients

Who this might be right for
Motor Neurone Disease
Sheffield Teaching Hospitals NHS Foundation Trust 15
Large-scale testing (Phase 3)Study completedNCT04414345
What this trial is testing

HEALEY ALS Platform Trial - Regimen C CNM-Au8

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 161
Testing effectiveness (Phase 2)Study completedNCT01083667
What this trial is testing

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Familial Amyotrophic Lateral Sclerosis
Weill Medical College of Cornell University 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04055623
What this trial is testing

T-regulatory Cells in ALS

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
The Methodist Hospital Research Institute 12
Large-scale testing (Phase 3)Study completedNCT01281189
What this trial is testing

Phase 3 Study of Dexpramipexole in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 942
Large-scale testing (Phase 3)UnknownNCT03690791
What this trial is testing

Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
Gold Coast Hospital and Health Service 17
Not applicableActive Not RecruitingNCT07796776
What this trial is testing

The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition

Who this might be right for
Inclusion Body Myositis (IBM)Motor Neuron Disease, Amyotrophic Lateral Sclerosis
IRCCS San Raffaele 30
Not applicableLooking for participantsNCT06820008
What this trial is testing

Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neurone Disease
University of Dublin, Trinity College 60
Large-scale testing (Phase 3)Study completedNCT00125203
What this trial is testing

Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisSialorrhea
The University of Texas Health Science Center at San Antonio 20
Early research (Phase 1)Study completedNCT04894240
What this trial is testing

Monepantel in Individuals With Motor Neurone Disease

Who this might be right for
Motor Neuron Disease
Neurizon Therapeutics Limited 12
Testing effectiveness (Phase 2)Ended earlyNCT03705390
What this trial is testing

A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
University of Birmingham 11
Testing effectiveness (Phase 2)Study completedNCT00243932
What this trial is testing

Clinical Trial of High Dose CoQ10 in ALS

Who this might be right for
Amyotrophic Lateral SclerosisLou Gehrig's Disease
Columbia University 185
Next Page